A pill to fight postpartum depression? For the first time, the United States Medicines Agency has just authorized the marketing of a drug to combat the effects of depression after the birth of a child, reported the Washington Post.
The doctor Kristina M. Deligiannidis conducted a large study of the named pill Zuranolone tablet. Taken daily at home for two weeks, it would drastically reduce the effects of depression in young mothers, and this starting from the third day of treatment, according to the doctor and researcher.
Nearly half of young mothers affected by postpartum depression
Until now, the only way to combat postpartum depression through medication was in the hospital, where women were treated intravenously for 60 hours. Zuranolone acts directly on neurotransmitters that regulate fear, anxiety or stress, all symptoms of postpartum depression that young mothers experience for several months.
The Medicines Agency not recommended however, women who drive or breastfeed while taking the pill. Serious, temporary restrictions, time to better evaluate the side effects.
Read also: Postpartum depression: no, motherhood is not “just happiness”
In the United States, one in eight American women suffer from it after giving birth, and the disease is estimated to affect nearly half of young mothers worldwide according to a recent study.
If it is for now impossible to know if one day this drug will be authorized in France, it will hopefully reduce the alarming numbers of postpartum depression across the Atlantic. Because in the United States, depression and mental illness are responsible for 9% of pregnancy-related deaths.
Source: Madmoizelle
Mary Crossley is an author at “The Fashion Vibes”. She is a seasoned journalist who is dedicated to delivering the latest news to her readers. With a keen sense of what’s important, Mary covers a wide range of topics, from politics to lifestyle and everything in between.
